
A recent study reveals a significant advancement in the treatment of progeria, a rare accelerated-aging disorder marked by severe cardiovascular decline. Researchers have found that LAV-BPIFB4 enhances cardiac performance by improving cellular resilience pubmed.ncbi.nlm.nih.gov/41022702/













